Arch Therapeutics announced that the 510 premarket notification for AC5 Topical Gel has been reviewed and cleared by the FDA, allowing for the product to be marketed. AC5 Topical Gel is a topical dressing indicated for use in the management of partial and full-thickness wounds, such as pressure sores, leg ulcers, diabetic ulcers, and surgical wounds.
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Arch Therapeutics (ARTH) initiated with a Buy at Ladenburg. 2. International Money Express (IMXI) initiated with a Buy at BTIG. 3. Intercept (ICPT) initiated with a Buy at Roth Capital. 4. Huntington Ingalls (HII) initiated with a Buy at Buckingham. 5. Zogenix (ZGNX) initiated with an Outperform at Northland. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.